Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Aethlon Medical, Inc.
Type
Public
Traded as NASDAQ: AEMD
Genre Biotechnology
Headquarters San Diego, California, USA
Website www.aethlonmedical.com

Aethlon Medical Inc. is a public company based in San Diego, California that trades on the NASDAQ under the ticker symbol "AEMD." Aethlon is said to develop medical devices to treat infectious disease and cancer by filtering harmful substances such as viruses from the blood.

In development by Aethlon is the Hemopurifier, described as a single-use disposable cartridge for use with dialysis machines and other blood circulatory pumps. During October, 2014, the Hemopurifier was used as an adjunct therapy in the treatment of a patient who was suffering from Ebola. The patient subsequently recovered, although it was not clear which of several experimental therapies, if any, were responsible for his recovery. The FDA subsequently approved the device for testing in up to 20 infected Ebola cases in the United States.


Investment goal date:
Dividends reinvested
Aethlon Medical, Inc. AEMD report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BANK OF AMERICA CORP /DE/
7000
Bank of New York Mellon Corp
17081
BlackRock Inc.
74118
Creative Planning
15101
DAVIDSON D A & CO
1698
DEUTSCHE BANK AG\
132
GEODE CAPITAL MANAGEMENT, LLC
24234
NORTHERN TRUST CORP
15527
Plante Moran Financial Advisors, LLC
881
PNC FINANCIAL SERVICES GROUP, INC.
5000
Timber Creek Capital Management LLC
40
UBS Group AG
1189
Vanguard Group, Inc
95390
Major Shareholders
Name Relationship
Total Shares
Holding stocks